Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
06-2023 | 06-2022 | 06-2021 | 06-2020 | 06-2019 | |
Sales | 4,222,993 | 3,578,127 | 3,196,825 | 2,957,013 | 2,606,572 |
Cost of Goods | 1,867,331 | 1,553,816 | 1,357,725 | 1,239,227 | 1,112,501 |
Gross Profit | 2,355,662 | 2,024,311 | 1,839,100 | 1,717,786 | 1,494,071 |
Operating Expenses | 1,224,122 | 1,024,841 | 936,147 | 908,354 | 915,309 |
Operating Income | 1,131,871 | 1,000,286 | 903,678 | 809,659 | 579,263 |
Interest Expense | 47,379 | 22,312 | 23,627 | 39,356 | 36,156 |
Other Income | 17,172 | -17,491 | 3,611 | -37,215 | -24,260 |
Pre-tax Income | 1,101,664 | 960,483 | 883,662 | 733,088 | 518,847 |
Income Tax | 204,108 | 181,046 | 409,157 | 111,414 | 114,255 |
Net Income Continuous | 897,556 | 779,437 | 474,505 | 621,674 | 404,592 |
Net Income | $897,556 | $779,437 | $474,505 | $621,674 | $404,592 |
EPS Basic Total Ops | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 |
EPS Basic Continuous Ops | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 |
EPS Diluted Total Ops | 6.09 | 5.30 | 3.24 | 4.27 | 2.80 |
EPS Diluted Continuous Ops | 6.09 | 5.30 | 3.24 | 4.27 | 2.80 |
EPS Diluted Before Non-Recurring Items | 6.44 | 5.79 | 5.33 | 4.76 | 3.64 |
EBITDA(a) | $1,329,433 | $1,194,127 | $1,095,196 | $991,032 | $730,058 |